Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
|
| gptkbp:activeIngredient |
gptkb:ethinyl_estradiol
norethindrone |
| gptkbp:alternativeName |
Norinyl 1+35
|
| gptkbp:ATCCode |
gptkb:G03AA05
|
| gptkbp:containsEstrogen |
gptkb:ethinyl_estradiol
|
| gptkbp:containsProgestin |
norethindrone
|
| gptkbp:contraindication |
gptkb:cancer
gptkb:liver_disease history of thromboembolic disorders known or suspected pregnancy |
| gptkbp:drugClass |
oral contraceptive
|
| gptkbp:form |
0.035 mg ethinyl estradiol
1 mg norethindrone combination pill |
| https://www.w3.org/2000/01/rdf-schema#label |
Norinyl-100
|
| gptkbp:marketedAs |
gptkb:Pfizer
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
FDA approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness irregular bleeding |
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:mestranol
|
| gptkbp:bfsLayer |
8
|